Continuation of R&D Activities and R&D Expenses of ¥87 Million
First written in FY2018-Q3. 1 of 29 entries say "Restated". Latest entry: FY2026.
26 other companies' latest entry also says "Other".
- FY2026Full-year R&D expenses decreasedAnnual report
「R&D expenses for the fiscal year amounted to ¥177 million.」
Full-year R&D expenses decreased from ¥249 million in the previous fiscal year to ¥177 million, while the company continued to develop new services, improve productivity, develop DX talent, strengthen its IT and digital infrastructure, and build AI agents. - FY2025Full-year R&D expenses increasedAnnual report
「The total R&D expenses for the current consolidated fiscal year were ¥249 million.」
Full-year R&D expenses increased from ¥208 million in the previous fiscal year to ¥249 million. The company is focusing on developing new services, improving productivity, developing digital transformation (DX) talent, and strengthening its IT and digital infrastructure. - FY2025-H1Increase in interim research and development expensesAnnual report
「The total R&D expenses for the interim consolidated fiscal period were ¥116 million. There were no material changes in the status of the Group's R&D activities during the interim consolidated fiscal period.」
Interim R&D expenses were ¥116 million, up from ¥113 million in the same period of the previous fiscal year. There were no material changes in the status of the R&D activities. - FY2024Full-year R&D expenses increasedAnnual report
「The total R&D expenses for the current consolidated fiscal year were ¥208 million.」
Full-year R&D expenses increased from ¥165 million in the previous fiscal year to ¥208 million. The company is focusing on developing new services, improving productivity, developing DX talent, and building IT and digital infrastructure. - FY2024-Q3Third-quarter R&D expenses increasedAnnual report
「The total R&D expenses for the nine-month cumulative period of the current consolidated fiscal year were ¥162 million. There were no material changes in the status of the Group's R&D activities during the nine-month cumulative period of the current consolidated fiscal year.」
R&D expenses for the nine-month cumulative period were ¥162 million, up ¥40 million from ¥122 million in the same period of the previous fiscal year. There were no material changes in the R&D activities themselves. - FY2024-Q2Second-quarter R&D expenses increasedAnnual report
「The total R&D expenses for the six-month cumulative period of the current consolidated fiscal year were ¥113 million. There were no material changes in the status of the Group's R&D activities during the six-month cumulative period of the current consolidated fiscal year.」
R&D expenses for the six-month cumulative period were ¥113 million, up from ¥80 million in the same period of the previous fiscal year. There were no material changes in the R&D activities themselves. - FY2024-Q1First-quarter R&D expenses decreasedAnnual report
「The total R&D expenses for the three-month cumulative period of the current consolidated fiscal year were ¥62 million. There were no material changes in the status of the Group's R&D activities during the three-month cumulative period of the current consolidated fiscal year.」
R&D expenses for the three-month cumulative period were ¥62 million, up from ¥43 million in the same period of the previous fiscal year, although the comparison is with the full-year figure of ¥165 million for the previous fiscal year, covering different periods. There were no material changes in the status of the R&D activities. - FY2023Full-year R&D expenses increasedAnnual report
「The total R&D expenses for the current consolidated fiscal year were ¥165 million.」
Full-year R&D expenses increased from ¥95 million in the previous fiscal year to ¥165 million. R&D in DX, CIM, disaster prevention and mitigation, compact cities, and extending infrastructure service life continued. - FY2023-Q3Third-quarter R&D expenses increasedAnnual report
「The total R&D expenses for the nine-month cumulative period of the current consolidated fiscal year were ¥122 million.」
R&D expenses for the nine-month cumulative period were ¥122 million, up ¥60 million from ¥62 million in the same period of the previous fiscal year. However, there were no material changes in the status of the R&D activities. - FY2023-Q2Second-quarter R&D expenses increasedAnnual report
「The total R&D expenses for the six-month cumulative period of the current consolidated fiscal year were ¥80 million. There were no material changes in the status of the Group's R&D activities during the six-month cumulative period of the current consolidated fiscal year.」
R&D expenses for the six-month cumulative period were ¥80 million, up from ¥40 million in the same period of the previous fiscal year. However, there were no material changes in the status of the R&D activities. - FY2023-Q1First-quarter R&D expenses increasedAnnual report
「The total R&D expenses for the three-month cumulative period of the current consolidated fiscal year were ¥43 million. There were no material changes in the status of the Group's R&D activities during the three-month cumulative period of the current consolidated fiscal year.」
R&D expenses for the three-month cumulative period were ¥43 million, up from ¥18 million in the same period of the previous fiscal year. There were no material changes in the R&D activities themselves. - FY2022RestatedAnnual report
「The total R&D expenses for the current consolidated fiscal year were ¥95 million.」
R&D expenses were ¥95 million, broadly in line with ¥95 million in the previous fiscal year. R&D in disaster prevention and mitigation, smart cities, extending service life, and ICT continued. - FY2022-Q3Third-quarter R&D expenses decreased year on yearAnnual report
「The total R&D expenses for the nine-month cumulative period of the current consolidated fiscal year were ¥62 million. There were no material changes in the status of the Group's R&D activities during the nine-month cumulative period of the current consolidated fiscal year.」
R&D expenses for the nine-month cumulative period were ¥62 million, down ¥16 million from ¥78 million in the same period of the previous fiscal year. There were no material changes in the status of the R&D activities. - FY2022-Q2Second-quarter R&D expenses edged downAnnual report
「The total R&D expenses for the six-month cumulative period of the current consolidated fiscal year were ¥40 million. There were no material changes in the status of the Group's R&D activities during the six-month cumulative period of the current consolidated fiscal year.」
R&D expenses for the six-month cumulative period were ¥40 million, down ¥1 million from ¥41 million in the same period of the previous fiscal year. There were no material changes in the status of the R&D activities. - FY2022-Q1First-quarter R&D expenses decreasedAnnual report
「The total R&D expenses for the three-month cumulative period of the current consolidated fiscal year were ¥18 million. There were no material changes in the status of the Group's R&D activities during the three-month cumulative period of the current consolidated fiscal year.」
R&D expenses for the three-month cumulative period were ¥18 million, down from ¥24 million in the same period of the previous fiscal year. There were no material changes in the status of the R&D activities. - FY2021Full-year R&D expenses increasedAnnual report
「The total R&D expenses for the current consolidated fiscal year were ¥95 million.」
Full-year R&D expenses increased from ¥93 million in the previous fiscal year to ¥95 million. R&D in advance preparation for post-disaster recovery, smart cities and compact cities, extending service life, and ICT continued. - FY2021-Q3Third-quarter R&D expenses decreasedAnnual report
「The total R&D expenses for the nine-month cumulative period of the current consolidated fiscal year were ¥64 million. There were no material changes in the status of the Group's R&D activities during the nine-month cumulative period of the current consolidated fiscal year.」
R&D expenses for the nine-month cumulative period were ¥64 million, down ¥14 million from ¥78 million in the same period of the previous fiscal year. There were no material changes in the status of the R&D activities. - FY2021-Q2Second-quarter R&D expenses decreasedAnnual report
「The total R&D expenses for the six-month cumulative period of the current consolidated fiscal year were ¥41 million. There were no material changes in the status of the Group's R&D activities during the six-month cumulative period of the current consolidated fiscal year.」
R&D expenses for the six-month cumulative period were ¥41 million, down from ¥54 million in the same period of the previous fiscal year. There were no material changes in the status of the R&D activities. - FY2021-Q1First-quarter R&D expenses increasedAnnual report
「The total R&D expenses for the three-month cumulative period of the current consolidated fiscal year were ¥24 million. There were no material changes in the status of the Group's R&D activities during the three-month cumulative period of the current consolidated fiscal year.」
R&D expenses for the three-month cumulative period were ¥24 million, up from ¥22 million in the same period of the previous fiscal year. There were no material changes in the status of the R&D activities. - FY2020Full-year R&D expenses decreasedAnnual report
「The total R&D expenses for the current consolidated fiscal year were ¥93 million.」
Full-year R&D expenses decreased from ¥144 million in the previous fiscal year to ¥93 million, while R&D activities in advance preparation for post-disaster recovery, compact cities, extending service life, and ICT continued. - FY2020-Q3Third-quarter R&D expenses decreasedAnnual report
「The total R&D expenses for the nine-month cumulative period of the current consolidated fiscal year were ¥78 million. There were no material changes in the status of the Group's R&D activities during the nine-month cumulative period of the current consolidated fiscal year.」
R&D expenses for the nine-month cumulative period were ¥78 million, down from ¥107 million in the same period of the previous fiscal year. There were no material changes in the status of the R&D activities. - FY2020-Q2Second-quarter research and development expense disclosedAnnual report
「The total R&D expenses for the six-month cumulative period of the current consolidated fiscal year were ¥54 million. There were no material changes in the status of the Group's R&D activities during the six-month cumulative period of the current consolidated fiscal year.」
The company disclosed total R&D expenses of ¥54 million for the six-month cumulative period and stated that there were no material changes in the status of its R&D activities. - FY2020-Q1Update to first-quarter R&D expensesAnnual report
「The total R&D expenses for the three-month cumulative period of the current consolidated fiscal year were ¥22 million. There were no material changes in the status of the Group's R&D activities during the three-month cumulative period of the current consolidated fiscal year.」
The company disclosed total R&D expenses of ¥22 million for the three-month cumulative period and stated that there were no material changes in the status of its R&D activities. - FY2019Full-year R&D expenses increasedAnnual report
「The total R&D expenses for the current consolidated fiscal year were ¥144 million.」
Full-year R&D expenses were ¥144 million, up from ¥118 million in the previous fiscal year. R&D activities in advance preparation for post-disaster recovery, compact cities, extending infrastructure service life, and ICT and CIM continued without material changes. - FY2019-Q3Update to R&D expenses for the first 3 quartersAnnual report
「The total R&D expenses for the nine-month cumulative period of the current consolidated fiscal year were ¥107 million. There were no material changes in the status of the Group's R&D activities during the nine-month cumulative period of the current consolidated fiscal year.」
Total R&D expenses for the nine-month cumulative period were ¥107 million, and there were no material changes in the status of the R&D activities. - FY2019-Q2Second-quarter research and development expense disclosedAnnual report
「The total R&D expenses for the six-month cumulative period of the current consolidated fiscal year were ¥72 million. There were no material changes in the status of the Group's R&D activities during the six-month cumulative period of the current consolidated fiscal year.」
The company disclosed total R&D expenses of ¥72 million for the six-month cumulative period and stated that there were no material changes in the status of its R&D activities. - FY2019-Q1First-quarter research and development expense disclosedAnnual report
「The total R&D expenses for the three-month cumulative period of the current consolidated fiscal year were ¥38 million. There were no material changes in the status of the Group's R&D activities during the three-month cumulative period of the current consolidated fiscal year.」
The company disclosed total R&D expenses of ¥38 million for the three-month cumulative period and stated that there were no material changes in the status of its R&D activities. - FY2018Full-year research and development expense disclosedAnnual report
「The total R&D expenses for the current consolidated fiscal year were ¥118 million.」
In addition to the ¥87 million reported for the nine-month cumulative period, total full-year R&D expenses of ¥118 million were disclosed. The reported R&D activities included advance preparation for post-disaster recovery, urban redevelopment, extending service life, and ICT. - FY2018-Q3First statedAnnual report
「The total R&D expenses for the nine-month cumulative period of the current consolidated fiscal year were ¥87 million. There were no material changes in the status of the Group's R&D activities during the nine-month cumulative period of the current consolidated fiscal year.」
The company disclosed total R&D expenses of ¥87 million for the nine-month cumulative period and stated that there were no material changes in the status of its R&D activities.